A recent article published in the Journal of Clinical Pathways breaks down some of the benefits and challenges facing precision benefit design, a framework which aims to grapple with high-cost precision medicine treatments.
The author, Precision Health Economics’ Jason Shafrin, details three key challenges:
- Guaranteeing patient-centered formulary design;
- Measuring value using scientific best practices; and
- Informational obstacles.
” … Precision benefit design should take into account patient preferences, in addition to more traditional cost-effectiveness comparisons, to ensure each patient gets the treatment of highest value to them,” the article states.
To read the full article on the Journal of Clinical Pathways, click here.